Papillomavirus Clinical Presentation

  • Author: John D Shanley, MD, MPH; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Dec 29, 2011
 

History

The clinical history and presentation of human papillomavirus (HPV) infection vary based on the anatomic area involved. The predilection of certain genotypes of virus to infect certain epidermal sites largely determines areas of involvement.

  • Common cutaneous warts, or verrucae vulgaris, generally appear on keratinized skin, presumably at the site of inoculation. These appear as circumscribed, rough, hyperkeratotic papulonodules or plaques with irregular scaly surfaces. They develop most often on the hands, fingers, feet, and knees. In general, they are asymptomatic, but they may be painful with application of pressure. The patient discovers common cutaneous warts due to changes in the skin.
  • Palmoplantar warts appear on the acral surfaces of the feet and hands. They are notable for their thickness, which complicates treatment.
  • Flat warts, or verrucae plana, generally present as multiple small papules. They are often not obvious but may induce significant disturbances of pigmentation.
  • Oral warts are infection of the oral mucosa. Oral warts are subtle and are missed frequently but are fairly common.
  • Focal epithelial hyperplasia (Heck disease) is a disseminated HPV infection of the oral mucosa most commonly associated with HPV 32 and HPV 13. This condition may have a family predilection.
  • Epidermodysplasia verruciformis (EDV) is an autosomal recessive familial trait that increases susceptibility to a subset of wart generally not observed in populations without EDV. The condition generally begins in childhood and can affect almost any area of the body. The warts are generally subtle and flat and may initially be mistaken for tinea versicolor. The HPV genotypes associated with EDV include 3, 5, 8, 9, 10, 12, 14, 17, 20, 21, 23, 28, 38, 47, and 49. Recently, these viruses have been observed in patients who are immunosuppressed for organ transplantation or in patients with HIV infection. These individuals are at increased risk for skin cancer if not recognized and treated.
  • Genital infection manifests as a warty lesion on the genital or anal area, although they are often not initially recognized. Condyloma acuminata are single or multiple papules or nodules but may progress to large exophytic masses that resemble cauliflower. Flat condylomata (squamous intraepithelial neoplasia) are the most common lesions of the cervix but may develop on the vulva, anus, and male genitalia. They appear as white plaquelike growths. An additional malignant variant is the giant condyloma, or Buschke-Löwenstein tumor, generally regarded as a verrucous carcinoma. These most often involve the glans penis, perianal area, and foreskin. In addition to their large cauliflower shape, they tend to form abscesses and fistulas and tend to invade locally. Cervical infection generally goes unnoticed and is discovered during cervical examination or Papanicolaou (PAP) test.
  • Lloyd described Bowenoid papulosis as multicentric pigmented Bowen disease of the groin. It manifests as multiple, warty, red-brown papules in the anogenital region. These papules may coalesce.
Next

Physical

Abnormal accumulation of keratinized growths generally characterizes warts. Similarly, genital lesions are due to excessive skin growth. In the case of condylomata, the growths may become exuberant. Cervical intraepithelial lesions may be found upon examination of the cervix.

Previous
Next

Causes

For a detailed discussion of causes, see Pathophysiology.

Previous
 
 
Contributor Information and Disclosures
Author

John D Shanley, MD, MPH  Professor Emeritus, University of Connecticut; Professor of Preventive Medicine, Stony Brook Medical Center

John D Shanley, MD, MPH is a member of the following medical societies: American Association for the Advancement of Science, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Jeffrey D Band, MD  Professor of Medicine, Oakland University William Beaumont School of Medicine; Director, Division of Infectious Diseases and International Medicine, Corporate Epidemiologist, William Beaumont Hospital; Clinical Professor of Medicine, Wayne State University School of Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Charles V Sanders, MD  Edgar Hull Professor and Chairman, Department of Internal Medicine, Professor of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine at New Orleans; Medical Director, Medicine Hospital Center, Charity Hospital and Medical Center of Louisiana at New Orleans; Consulting Staff, Ochsner Medical Center

Charles V Sanders, MD is a member of the following medical societies: Alliance for the Prudent Use of Antibiotics, Alpha Omega Alpha, American Association for the Advancement of Science, American Association of University Professors, American Clinical and Climatological Association, American College of Physician Executives, American College of Physicians, American Federation for Medical Research, American Foundation for AIDS Research, American Geriatrics Society, American Lung Association, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Association for Professionals in Infection Control and Epidemiology, Association of American Medical Colleges, Association of American Physicians, Association of Professors of Medicine, Infectious Disease Society for Obstetrics and Gynecology, Infectious Diseases Society of America, Louisiana State Medical Society, Orleans Parish Medical Society, Royal Society of Medicine, Sigma Xi, Society of General Internal Medicine, Southeastern Clinical Club, Southern Medical Association, Southern Society for Clinical Investigation, and Southwestern Association of Clinical Microbiology

Disclosure: Nothing to disclose.

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References
  1. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003-2006. J Infect Dis. Aug 2011;204(4):566-73. [Medline].

  2. [Guideline] FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):626-9. [Medline]. [Full Text].

  3. Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. Dec 23 2011;60:1705-8. [Medline].

  4. FDA. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):626-9. [Medline].

  5. FDA. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):630-2. [Medline].

  6. Ault KA. Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine. Obstet Gynecol Clin North Am. Dec 2003;30(4):809-17. [Medline].

  7. Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med. May 5 1997;102(5A):28-37. [Medline].

  8. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. Jan 2003;16(1):1-17. [Medline].

  9. Carr J, Gyorfi T. Human papillomavirus. Epidemiology, transmission, and pathogenesis. Clin Lab Med. Jun 2000;20(2):235-55. [Medline].

  10. Cox JT. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results. J Clin Virol. Jul 2009;45 Suppl 1:S3-S12. [Medline].

  11. Fazel N, Wilczynski S, Lowe L, Su LD. Clinical, histopathologic, and molecular aspects of cutaneous human papillomavirus infections. Dermatol Clin. Jul 1999;17(3):521-36, viii. [Medline].

  12. Huang CM. Human papillomavirus and vaccination. Mayo Clin Proc. Jun 2008;83(6):701-6; quiz 706-7. [Medline].

  13. Huh WK. Human papillomavirus infection: a concise review of natural history. Obstet Gynecol. Jul 2009;114(1):139-43. [Medline].

  14. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. May 5 1997;102(5A):3-8. [Medline].

  15. Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol. Jun 1999;42(2):206-20. [Medline].

  16. Siddiqui MA, Perry CM. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs. 2006;66(9):1263-71; discussion 1272-3. [Medline].

  17. Tjalma WA, Arbyn M, Paavonen J, van Waes TR, Bogers JJ. Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer. Int J Gynecol Cancer. Sep-Oct 2004;14(5):751-61. [Medline].

  18. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. Oct 15 2002;35(Suppl 2):S210-24. [Medline].

Previous
Next
 
Verrucous warts in a patient with HIV infection.
Plantar warts.
Flat wart.
Table 1. Association of HPV Types With Morphology and Site of Skin Lesions
LesionLocationHPV Genotype
Common wartMostly hands2, 4
Plantar wartBottom of feet1
Mosaic wartHands and feet2
Flat wartArms, face, knees3, 10, 28, 41
Butcher wartHand7
Extragenital Bowen diseaseUpper and lower extremities, head2, 3, 5, 16, 18, 20, 31, 33, 34, 54, 56, 58, 61, 62, 73
Macular plaques of epidermodysplasia verruciformisLight-exposed areas5, 8, 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 47, 50
Table 2. HPV Types Associated With Anogenital Lesions
LesionsHPV Genotype
Genital warts6, 11
Flat condylomata6, 11, 16, 18, 31
Cervical intraepithelial neoplasia16, 18, 31, 33, 35, 39, 42, 43, 44, 45, 51, 52, 56
Bowen disease6, 11
Buschke-Löwenstein tumors6, 11
Vulvar intraepithelial neoplasia16 (occasionally 6, 11)
Cervical cancer16, 18 (strong association)
31, 33, 35, 45, 51, 52, 56 (moderate association)
6, 11, 42, 43, 44 (weak association)
Penile intraepithelial neoplasia16, 18
Anal intraepithelial neoplasia16 (rarely 6, 11, 18, 33)
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.